37 results
8-K
EX-99.2
FATE
Fate Therapeutics Inc
2 Apr 20
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies
4:55pm
there will be delays across our studies. We are committed to the health and safety of our employees and partners, and have implemented a remote work … in line with guidance from the U.S. Centers for Disease Control and Prevention (CDC) and the State of California to protect the health and safety
424B5
687g8
10 Jun 20
Prospectus supplement for primary offering
12:00am
424B5
ynkmgb70d0eh xj1
8 Jun 20
Prospectus supplement for primary offering
4:11pm